Ipamorelin & CJC-1295 No DAC Research Combo Pack Limitless Biotech Ipamorelin & CJC-1295 No DAC Research Combo Pack Limitless Biotech Ipamorelin & CJC-1295 (no DAC) Research Combo Pack The research combo pack combines two of the most widely studied growth hormone secretagogues: Ipamorelin, a selective ghrelin receptor agonist, and CJC-1295 without a drug affinity complex (DAC). The formulation is designed for laboratory use in cell culture or animal studies where precise dosing of each peptide is essential. By providing both peptides in a single package, researchers can streamline experimental protocols that investigate synergistic effects on growth hormone release, tissue regeneration, or metabolic regulation. Ipamorelin, 5mg / 10mg Ipamorelin is supplied as pre-measured vials containing either 5 mg or 10 mg of the peptide. The higher concentration allows for flexible dosing regimens while maintaining a small vial volume to reduce waste and storage space. In vitro assays often require microgram quantities, so the 5 mg vial is ideal for serial dilution experiments, whereas the 10 mg vial supports in vivo studies that demand larger injection volumes. Mod GRF 1-29 (CJC-1295 no DAC) Also known as Mod GRF 1-29, this peptide lacks the DAC sequence that normally prolongs its half-life. The absence of DAC results in a shorter residence time in circulation, which can be advantageous when researchers wish to observe rapid clearance or study acute pharmacodynamics. Mod GRF 1-29 retains full activity at growth hormone-releasing hormone receptors, enabling robust stimulation of endogenous GH secretion without the confounding influence of sustained release. Reconstitution Solution Each peptide vial is supplied with a sterile reconstitution buffer—typically 0.9 % saline or a proprietary isotonic solution—to facilitate accurate dilution.